Frontlight ResearchEarly access
CompletedPhase 4
Multicenter study on patient’s ability to independently and safely use of Sildenafil 100 mg for erectile dysfunction.
Key facts
- Who runs it
- ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
- Where
- Poland8 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 200 people enrolled
- Started
- 17 Feb 2026
- Ended
- 14 Apr 2026
- Type of study
- Interventional
- Record updated
- 23 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Males aged 18 years* and older sexually active and planning to have sexual interactions
- Signed informed consent to participate in the study prior to commencing study procedures
- Participants able to understand and follow study procedures
Who cannot take part
- Symptoms of active infection
- Severe physical or mental disease that might hamper the realization of the trial according to the protocol
- Lack of reading and writing skills or comprehension in Polish
- Unreliability or lack of cooperation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The primary objective of the study is to assess whether participants using dedicated diagnostic tool can independently make safe decision whether it is appropriate for them to use or not use sildenafil in dose of 100 mg.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- A multicenter, prospective clinical TRrial evaluating patient’s ability to make an independent and safe decision regarding the USe of the medicinal product Sildenafil Polpharma100 mg indicated in the Treatment of erectile dysfunction. TRUST Trial on Responsible Use and Self-assessed Treatment.
- Record updated
- 23 March 2026